Detalles de la búsqueda
1.
Empagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med
; 388(2): 117-127, 2023 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36331190
2.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Lancet
; 403(10424): 379-390, 2024 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38109916
3.
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.
J Am Soc Nephrol
; 35(2): 202-215, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38082486
4.
Methods Article for a Study Protocol: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in Chronic Kidney Disease.
Am J Nephrol
; 55(2): 262-272, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37903483
5.
Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEY.
Clin Exp Nephrol
; 2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38643286
6.
Consistent effects of empagliflozin on cardiovascular and kidney outcomes irrespective of diabetic kidney disease categories: Insights from the EMPA-REG OUTCOME trial.
Diabetes Obes Metab
; 22(12): 2335-2347, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32744354
7.
Correction to: Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
BMC Nephrol
; 21(1): 200, 2020 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32466752
8.
Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
BMC Nephrol
; 21(1): 167, 2020 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32380961
9.
Detection of carnosinase-1 in urine of healthy individuals and patients with type 2 diabetes: correlation with albuminuria and renal function.
Amino Acids
; 51(1): 17-25, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29961141
10.
Identification and characterisation of carnostatine (SAN9812), a potent and selective carnosinase (CN1) inhibitor with in vivo activity.
Amino Acids
; 51(1): 7-16, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29922921
11.
Carnosinase concentration, activity, and CNDP1 genotype in patients with type 2 diabetes with and without nephropathy.
Amino Acids
; 51(4): 611-617, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30610469
12.
Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetes.
J Diabetes Complications
; 37(9): 108588, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37633072
13.
Different conformational forms of serum carnosinase detected by a newly developed sandwich ELISA for the measurements of carnosinase concentrations.
Amino Acids
; 43(1): 143-51, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22349764
14.
Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials.
Diabetes Care
; 45(6): 1445-1452, 2022 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35472672
15.
Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.
Clin Kidney J
; 13(4): 722, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32905262
16.
Human carnosinase 1 overexpression aggravates diabetes and renal impairment in BTBROb/Ob mice.
J Mol Med (Berl)
; 98(9): 1333-1346, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32803273
17.
Serum Carnosinase-1 and Albuminuria Rather than the CNDP1 Genotype Correlate with Urinary Carnosinase-1 in Diabetic and Nondiabetic Patients with Chronic Kidney Disease.
J Diabetes Res
; 2019: 6850628, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31950064
18.
Methylglyoxal down-regulates the expression of cell cycle associated genes and activates the p53 pathway in human umbilical vein endothelial cells.
Sci Rep
; 9(1): 1152, 2019 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30718683
19.
The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes.
J Diabetes Complications
; 32(3): 291-297, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29352693
20.
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.
Clin Kidney J
; 11(6): 749-761, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30524708